Skip to main content
Search
section
Global
News
Careers
Language & Country Selector for Desktop
Sandoz
|
en
Choose Location
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Brazil |
pt
Canada |
en
Canada |
fr
Mexico |
es
United States |
en
Australia |
en
Japan |
ja
Korea |
ko
Mainland China |
zh
Austria |
de
Belgium |
fr
Belgium |
nl
Bulgaria |
bg
Croatia |
hr
Czech Republic |
cs
Denmark |
da
Finland |
fi
France |
fr
Germany |
de
Hungary |
hu
Italy |
it
Netherlands |
nl
Norway |
no
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Slovakia |
sk
Spain |
es
Sweden |
sv
Switzerland |
de
Switzerland |
fr
United Kingdom |
en
Global |
en
Sandoz |
en
Saudi Arabia |
ar
Turkey |
tr
Language & Country Selector for Mobile
Sandoz
Choose Location
international
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Australia |
en
Austria |
de
Belgium |
fr
Belgium |
nl
Brazil |
pt
Bulgaria |
bg
Canada |
en
Canada |
fr
Croatia |
hr
Czech Republic |
cs
Denmark |
da
Finland |
fi
France |
fr
Germany |
de
Hungary |
hu
Italy |
it
Japan |
ja
Korea |
ko
Mainland China |
zh
Mexico |
es
Netherlands |
nl
Norway |
no
Global |
en
Sandoz |
en
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Saudi Arabia |
ar
Slovakia |
sk
Spain |
es
Sweden |
sv
Switzerland |
de
Switzerland |
fr
Turkey |
tr
United Kingdom |
en
United States |
en
Menu
About Sandoz
Our Purpose and Ambition
What We Do
Innovation, Quality and Supply
Corporate Responsibility
Ethics, Risk and Compliance
Sandoz external funding
Malaria Initiative
Novartis Access
World Child Cancer
Our History
Investor Information
About Sandoz
Products & Services
Disease Areas
Anti-Infectives
Respiratory
Endocrinology
Immunology
Oncology
Biopharmaceuticals
Sandoz Biosimilars
Sandoz Biosimilar Portfolio and Pipeline
About Biologics
Development of Biosimilars
Information for Patients
Prescription Medicines
Over-The-Counter Medicines
Partnerships and Collaborations
Biotech Cooperations
Business to Business (B2B)
Biotech Cooperations
Business to Business (B2B)
Business to Business (B2B)
Products & Services
People & Culture
Sandoz Leadership
Richard Saynor
Francisco Ballester
Martin Bischof
Colin Bond
Pierre Bourdage
Valerie Chew
Claire D'Abreu-Hayling
Glenn A. Gerecke, PhD
Rebecca Guntern
Keren Haruvi
Steffen Kurzawa
Inge Maes
Ingrid Sollerer
Diversity & Inclusion
Associate Stories
Investors & Media
Sandoz spin-off
Media Releases
Media Library
Media Contacts
Novartis Annual Reporting Suite
Careers
Working at Sandoz
Diversity & Inclusion
Associate Stories
Job Search
Our Teams
Sandoz Technology
Sandoz People & Organization
Careers
News
News Archive
Media Releases
Publications
Stay Up-To-Date
News
Contacts
Home
Stories
Story Navigation
Story Navigation
All Topics
Discovery
From Our Labs
People & Culture
Access to Healthcare
Patient Perspectives
icon
List View
No Results Found